Literature DB >> 28408468

Avoidance of voiding cystourethrography in infants younger than 3 months with Escherichia coli urinary tract infection and normal renal ultrasound.

Jean-Yves Pauchard1, Hassib Chehade2, Chafika Zohra Kies1, Eric Girardin3, Francois Cachat2, Mario Gehri1.   

Abstract

BACKGROUND AND
OBJECTIVE: Urinary tract infection (UTI) represents the most common bacterial infection in infants, and its prevalence increases with the presence of high-grade vesicoureteral reflux (VUR). However, voiding cystourethrography (VCUG) is invasive, and its indication in infants <3 months is not yet defined. This study aims to investigate, in infants aged 0-3 months, if the presence of Escherichia coli versus non-E. coli bacteria and/or normal or abnormal renal ultrasound (US) could avoid the use of VCUG.
METHOD: One hundred and twenty-two infants with a first febrile UTI were enrolled. High-grade VUR was defined by the presence of VUR grade ≥III. The presence of high-grade VUR was recorded using VCUG, and correlated with the presence of E. coli/non-E. coli UTI and with the presence of normal/abnormal renal US. The Bayes theorem was used to calculate pretest and post-test probability.
RESULTS: The probability of high-grade VUR was 3% in the presence of urinary E. coli infection. Adding a normal renal US finding decreased this probability to 1%. However, in the presence of non-E. coli bacteria, the probability of high-grade VUR was 26%, and adding an abnormal US finding increased further this probability to 55%.
CONCLUSIONS: In infants aged 0-3 months with a first febrile UTI, the presence of E. coli and normal renal US findings allow to safely avoid VCUG. Performing VCUG only in infants with UTI secondary to non-E. coli bacteria and/or abnormal US would save many unnecessary invasive procedures, limit radiation exposure, with a very low risk (<1%) of missing a high-grade VUR. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Non E. Coli bacteria; infant; renal ultrasound; urinary tract infection; vesicoureteral reflux; voiding cystourethrography.

Mesh:

Year:  2017        PMID: 28408468     DOI: 10.1136/archdischild-2016-311587

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  E. coli versus Non-E. coli Urinary Tract Infections in Children: A Study from a Large Tertiary Care Center in Saudi Arabia.

Authors:  Abdullah Al Nafeesah; Khaled Al Fakeeh; Syed Chishti; Tahir Hameed
Journal:  Int J Pediatr Adolesc Med       Date:  2021-05-21

Review 2.  Updated Italian recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children.

Authors:  Anita Ammenti; Irene Alberici; Milena Brugnara; Roberto Chimenz; Stefano Guarino; Angela La Manna; Claudio La Scola; Silvio Maringhini; Giuseppina Marra; Marco Materassi; William Morello; Giangiacomo Nicolini; Marco Pennesi; Lorena Pisanello; Fabrizio Pugliese; Floriana Scozzola; Felice Sica; Antonella Toffolo; Giovanni Montini
Journal:  Acta Paediatr       Date:  2019-10-06       Impact factor: 2.299

Review 3.  Swiss consensus recommendations on urinary tract infections in children.

Authors:  Christoph Rudin; Guido Laube; Rodo von Vigier; Thomas J Neuhaus; Michael Buettcher; Johannes Trueck; Anita Niederer-Loher; Ulrich Heininger; Philipp Agyeman; Sandra Asner; Christoph Berger; Julia Bielicki; Christian Kahlert; Lisa Kottanattu; Patrick M Meyer Sauteur; Paolo Paioni; Klara Posfay-Barbe; Christa Relly; Nicole Ritz; Petra Zimmermann; Franziska Zucol; Rita Gobet; Sandra Shavit
Journal:  Eur J Pediatr       Date:  2020-07-03       Impact factor: 3.183

4.  Clinical and Microbial Etiology Characteristics in Pediatric Urinary Tract Infection.

Authors:  Jiandong Lu; Xiaozhu Liu; Yi Wei; Chengjun Yu; Jie Zhao; Ling Wang; Yang Hu; Guanghui Wei; Shengde Wu
Journal:  Front Pediatr       Date:  2022-04-07       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.